Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1774 studies found for:    "type 1 diabetes" OR "Diabetes Mellitus, Type 1"
Show Display Options
RSS Create an RSS feed from your search for:
"type 1 diabetes" OR "Diabetes Mellitus, Type 1"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed PROCHYMAL® (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM)
Conditions: Type 1 Diabetes Mellitus;   Type 1 Diabetes;   Diabetes Mellitus, Insulin-Dependent;   Juvenile Diabetes
Interventions: Drug: PROCHYMAL®;   Drug: Placebo
2 Completed Canakinumab Study in Individuals With Newly Diagnosed Type 1 Diabetes
Conditions: Type 1 Diabetes;   Preservation of Insulin Secretion;   Newly Diagnosed Type 1 Diabetes;   Canakinumab in Type 1 Diabetes
Intervention: Drug: canakinumab (anti IL-1beta)
3 Recruiting Evaluation of Vildagliptin (Galvus®) as add-on to Insulin in New-onset Type 1 Diabetes Mellitus
Conditions: Type 1 Diabetes;   Insulin Dependent Diabetes;   Juvenile Onset Diabetes Mellitus;   Autoimmune Diabetes
Intervention: Drug: Vildagliptin
4 Completed A Study to Assess the Safety of Single Doses of GSK189075 in Subjects With Type 1 Diabetes Mellitus
Conditions: Diabetes Mellitus, Type 1;   Type 1 Diabetes Mellitus
Interventions: Drug: GSK189075;   Drug: placebo
5 Unknown  The Influence of Partial Remission Phase of Type 1 Diabetes on Patient Outcome
Conditions: Diabetes Mellitus Type 1;   Remission of Type 1 Diabetes;   Chronic Complications of Diabetes
Intervention:
6 Active, not recruiting Imatinib Treatment in Recent Onset Type 1 Diabetes Mellitus
Conditions: Diabetes Mellitus, Type I;   Diabetes Mellitus, Insulin-Dependent, 1;   Type 1 Diabetes Mellitus;   Insulin-Dependent Diabetes Mellitus 1;   IDDM
Interventions: Drug: Imatinib Mesylate;   Drug: Placebo (For imatinib mesylate)
7 Completed
Has Results
Rituximab in New Onset Type 1 Diabetes
Condition: Type 1 Diabetes Mellitus
Intervention: Drug: Anti-CD20 (rituximab)
8 Completed Eating Disorders in Type 1 Diabetes: Mechanisms of Comorbidity
Conditions: Type 1 Diabetes;   Eating Disorder
Intervention:
9 Active, not recruiting DIABGAD - Trial to Preserve Insulin Secretion in Type 1 Diabetes Using GAD-Alum (Diamyd) in Combination With Vitamin D and Ibuprofen
Condition: Diabetes Mellitus, Type 1
Interventions: Biological: GAD-Alum (Diamyd) 20 µg;   Biological: GAD-Alum (Diamyd) 20 µg X 2;   Drug: Vitamin D;   Drug: Ibuprofen
10 Completed
Has Results
Intravenous CTLA4-lg Treatment in Recent Onset Type 1 Diabetes Mellitus
Condition: Type 1 Diabetes Mellitus
Interventions: Drug: CTLA-4 Ig;   Other: Placebo
11 Completed Improving Metabolic Assessments in Type 1 Diabetes Mellitus Clinical Trials
Condition: Diabetes Mellitus, Type 1
Interventions: Procedure: Mixed Meal Tolerance Test;   Procedure: Glucagon Stimulation Test
12 Completed TRX4 Monoclonal Antibody in Type 1 Diabetes (T1 DM)
Condition: Type 1 Diabetes Mellitus
Intervention: Drug: Otelixizumab
13 Recruiting Tocilizumab (TCZ) in New-onset Type 1 Diabetes
Conditions: Type 1 Diabetes Mellitus;   New-onset Type 1 Diabetes Mellitus;   T1DM;   T1D
Interventions: Drug: Tocilizumab (TCZ);   Drug: Placebo
14 Unknown  Beta Cell Function in (Pre)Type 1 Diabetes
Condition: Type 1 Diabetes
Interventions: Drug: Glucose;   Device: Continuous glucose monitoring
15 Completed
Has Results
Autoimmunity-blocking Antibody for Tolerance in Recently Diagnosed Type 1 Diabetes
Condition: Diabetes Mellitus, Type 1
Interventions: Biological: Anti-CD3 mAb;   Other: Diabetes Standard of Care Treatment;   Dietary Supplement: Iron supplementation
16 Completed Effect of Pioglitazone on the Course of New Onset Type 1 Diabetes Mellitus
Condition: Type 1 Diabetes Mellitus
Interventions: Drug: pioglitazone;   Drug: Placebo control
17 Enrolling by invitation Incretin-based Therapy in Late Preclinical Type 1 Diabetes
Condition: Type 1 Diabetes
Interventions: Drug: Victoza®;   Drug: Placebo
18 Active, not recruiting EDCR Study - Etanercept Diamyd Combination Regimen -Open Trial to Evaluate Safety in Children With Type 1 Diabetes
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: GAD-Alum;   Drug: Vitamin D;   Drug: Etanercept
19 Enrolling by invitation Incretin-based Therapy in Preclinical Type 1 Diabetes in Adults
Condition: Type 1 Diabetes
Interventions: Drug: Victoza®;   Drug: Placebo
20 Completed Trial of Otelixizumab for Adults With Newly Diagnosed Type 1 Diabetes Mellitus (Autoimmune): DEFEND-1
Condition: Diabetes Mellitus, Type 1
Interventions: Biological: otelixizumab infusion plus physician determined standard of care;   Biological: placebo infusion plus physician determined standard of care

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years